- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic plaque psoriasis (CPP)
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Guselkumab – May 2025
Guselkumab: Injection 100 mg in 1 mL single use pre-filled pen; Tremfya®
Last updated
9 May 2025